Clinical Trial

Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-11-07; most recent amendment 2025-08-04.
Status change: Not Yet Recruiting → Recruiting 2022-01-27
Trial Details
NCT Number NCT05125939
Lead Sponsor Evergreen General Hospital, Taiwan
Collaborators: E-DA Hospital, E-Da Dachang Hospital, Chang Gung Memorial Hospital, Sepulveda Ambulatory Care Center, Veterans Affairs Greater Los Angeles Healthcare System
Conditions Adenoma Detection Rate, Colonoscopy
Enrollment 2,700 participants
Start Date 2021-11-20
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-07